Entera Bio Ltd.
NASDAQ:ENTX · NASDAQ Capital Market
+$0.07 today
Vol 0.05M · Avg 0.16M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-38.50%
Period High
$3.14
Period Low
$1.00
Latest
$1.23
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$328.84M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$165.02M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$147.74M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$143.56M
Agenus Inc.
NASDAQ:AGEN
$137.42M
Seer, Inc.
NASDAQ:SEER
$94.57M
Anixa Biosciences, Inc.
NASDAQ:ANIX
$84.04M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.95M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$55.20M
VistaGen Therapeutics, Inc.
VTGN
$18.88M
What is the latest ENTX filing?
The latest filing shown is DEF 14A dated Jun 3, 2026.
How many recent filings does ENTX have?
Intrinsic Alpha currently shows 20 recent filings for ENTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.